CONSENSUS AND META-ANALYSESSTRIDE BP: an international initiative for accurate blood pressure measurementStergiou, George S.a; O’Brien, Eoinb; Myers, Martinc; Palatini, Paolod; Parati, Gianfrancoe; the STRIDE BP Scientific Advisory BoardAuthor Information aHypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, Athens, Greece bThe Conway Institute, University College Dublin, Ireland cUniversity of Toronto, Schulich Heart Program. Division of Cardiology, Sunnybrook Health Sciences Centre, Toronto, Canada dDepartment of Medicine, University of Padova, Padova eDepartment of Medicine and Surgery, University of Milano-Bicocca, Istituto Auxologico Italiano, IRCCS, Cardiology Unit and Department of Cardiovascular, Neural and Metabolic Sciences, S.Luca Hospital, Milan, Italy Correspondence to Professor George S. Stergiou, MD, FRCP, Hypertension Center STRIDE-7, National and Kapodistrian University of Athens, School of Medicine, Third Department of Medicine, Sotiria Hospital, 152 Mesogion Avenue, Athens 11527, Greece. Tel: +30 2107763117; fax: +30 2107719981; e-mail: [email protected] Received 18 August, 2019 Accepted 24 September, 2019 Journal of Hypertension: March 2020 - Volume 38 - Issue 3 - p 395-399 doi: 10.1097/HJH.0000000000002289 Buy Metrics Abstract The diagnosis and management of hypertension is dependent upon accurate blood pressure (BP) measurement. Despite intense efforts over several decades by the international medical community worldwide, the use of inaccurate devices has resulted in the misdiagnosis and poor management of hypertension, which remains a largely unresolved public health problem. STRIDE BP (www.stridebp.org) is an international nonprofit organization the mission of which is to improve the accuracy of BP measurement and the diagnosis of hypertension. STRIDE BP comprises a group of 24 recognized experts in BP monitoring from across the world and operates in affiliation with the European Society of Hypertension, the International Society of Hypertension, and the World Hypertension League. In the first stage, STRIDE BP has reviewed 419 validations of 260 devices and approved 69% of them, providing recommendations on accurate devices for office, ambulatory and home BP measurement in adults, children and during pregnancy. At the next stage, STRIDE BP intends to develop programs for on-line training and tools for use in clinical practice leading to improved measurement of BP and better diagnosis of hypertension world-wide. Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.